Neurobiology and pharmacology
Withdrawal and complications
Treatment & Medications
Psych & Medical Comorbidities
Misc
100

Chronic alcohol use enhances this inhibitory neurotransmitter system, leading to receptor downregulation.

GABA-A

100

Most common timeline for onset of withdrawal symptoms after last drink

6–24 hours

100

This medication reduces heavy drinking by modulating opioid receptors.

naltrexone

100

Most common psychiatric comorbidity with AUD

major depressive disorder

100

Best initial step in suspected Wernicke encephalopathy.

IV thiamine BEFORE glucose

200

This excitatory receptor becomes upregulated in chronic alcohol use, contributing to withdrawal seizures.

NMDA (glutamate receptor)

200

This is the most sensitive early sign of alcohol withdrawal.

tremor

200

This mechanism explains disulfiram’s aversive effect.

acetaldehyde accumulation due to aldehyde dehydrogenase inhibition

200

Alcohol is a major risk factor for this arrhythmia, sometimes called “holiday heart.”

Which electrolyte abnormality increases risk of arrhythmia during withdrawal and must be corrected.

a-fib

hypomagnesemia

200

Best medication for AUD with severe liver disease

acamprosate. (naltrexone is contraindicated)

300

Alcohol increases dopamine release in this pathway, reinforcing addictive behavior

mesolimbic pathway

300

Peak timing for Delirium Tremens.

48–96 hours

300

This medication restores glutamate balance and is safest in liver disease

acamprosate

300

Alcohol withdrawal seizures are typically of this type.

generalized tonic-clonic seizures

300

Two best meds for reducing heavy drinking (not necessarily abstinence)

naltrexone and topiramate

400

AST:ALT ratio typically seen in alcoholic liver disease

2:1

400

A patient with AUD develops visual hallucinations but remains oriented and stable vitals.

alcoholic hallucinosis

400

Off-label medication that reduces cravings via GABA modulation and is renally cleared

topiramate

400

This hematologic finding is classically associated with chronic alcohol use even without anemia.

macrocytosis (elevated MCV)

400

Two key risk factors for severe withdrawal.

prior DTs and high daily intake

500

Chronic alcohol exposure alters this ion channel, contributing to tolerance via neuronal hyperexcitability.

voltage-gated calcium channels

500

triad defines a neurologic emergency in alcohol use disorder and requires immediate treatment

confusion, ataxia, and ophthalmoplegia

500

This long-acting injectable improves adherence in patients with poor compliance.

extended-release naltrexone

500

AUD significantly increases risk for this type of cancer in the upper GI tract

esophageal squamous cell carcinoma

500

Two neurotransmitter systems most implicated in withdrawal pathophysiology

GABA (↓) and glutamate (↑)